ID: ALA2295979

Max Phase: Preclinical

Molecular Formula: C4H4ClN3OS

Molecular Weight: 177.62

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(CCl)Nc1nncs1

Standard InChI:  InChI=1S/C4H4ClN3OS/c5-1-3(9)7-4-8-6-2-10-4/h2H,1H2,(H,7,8,9)

Standard InChI Key:  ZQMRUOLNPQGIHY-UHFFFAOYSA-N

Associated Targets(non-human)

Ehrlich 1318 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

P388 20296 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 177.62Molecular Weight (Monoisotopic): 176.9764AlogP: 0.72#Rotatable Bonds: 2
Polar Surface Area: 54.88Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.75CX Basic pKa: CX LogP: 0.21CX LogD: -0.44
Aromatic Rings: 1Heavy Atoms: 10QED Weighted: 0.68Np Likeness Score: -3.37

References

1. Hamama WS, Gouda MA, Badr MH, Zoorob HH.  (2013)  Synthesis, antioxidant, and antitumor evaluation of certain new N-substituted-2-amino-1,3,4-thiadiazoles,  22  (8): [10.1007/s00044-012-0336-z]
2. Zee-Cheng RK, Cheng CC..  (1979)  Antileukemic activity of substituted ureidothiazoles, ureidothiadiazoles, and related compounds.,  22  (1): [PMID:423179] [10.1021/jm00187a007]

Source